Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesEffect of Transdermal Teriparatide Administration on Bone Mineral Density in Postmenopausal Women
Journal of Clinical Endocrinology and Metabolism, 11/10/09
Cosman F et al. – Transdermal patch delivery of TPTD in postmenopausal women with osteoporosis for 6 months is safe and effective in increasing lumbar spine and total hip BMD.
Related Articles
Combination of Two Medications Help Postmenopausal Women with Osteoporosis
MedLinePlus, 10/30/09
Relevance Score: 81%
Amgen Provides Update on Status of Prolia Biologics License Application Submitted to the U.S. Food and Drug Administration
Amgen, 10/20/09
Relevance Score: 79%
Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis
Osteoporosis International, 10/30/09
Relevance Score: 78%
Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
Therapeutics and Clinical Risk Management, 10/16/09
Relevance Score: 69%
Teriparatide Outperforms Alendronate In Treating Steroid-induced Osteoporosis
ScienceDaily, 10/30/09
Relevance Score: 68%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study
Diabetes Research and Clinical Practice, 11/24/09
Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain
Journal of Orthopaedics and Traumatology, 11/24/09
DPP-4 Inhibitors in Clinical Practice
Postgraduate Medicine, 11/24/09
Sponsor
Article Search
Sponsor